Nectar Lifesciences Q4 Results

  • BSE: 532649
  • NSE: NECLIFE
  • ISIN: INE023H01027
  • Sector: Biotechnology & Drugs
BSE
33.32-0.68 (-2.00%)
Volume27.31 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
32.95-0.64 (-1.91%)
Volume7.24 L
Updated: Mon 25 Nov, 2024 | 15:15:07
Today: 33.32
33.32
52-Wk: 25.02
56.39

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Nectar Lifesciences Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 441.37344.13-%387.89-%
    Selling/ General/ Admin Expenses Total 23.9419.71-%20.31-%
    Depreciation/ Amortization 14.7014.78-%14.85-%
    Other Operating Expenses Total 61.0052.56-%59.80-%
    Total Operating Expense 407.57357.46-%385.59-%
    Operating Income 33.80-13.34-%2.30-%
    Net Income Before Taxes 11.11-17.56-%1.50-%
    Net Income 0.59-9.29-%3.68-%
    Diluted Normalized EPS 0.03-0.41-%0.16-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts